Skip to content

Does an absorbable poloxamer and sodium alginate gel applied during lower-back (lumbar) spine surgery reduce scar tissue and improve recovery?

Comparison of clinical and radiological outcomes in patients undergoing lumbar spine surgery with versus without an intraoperative poloxamer and sodium alginate-based barrier agent (Guardix-SG): a randomised controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14269651
Enrollment
20
Registered
2026-07-08
Start date
2025-07-29
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing lumbar spine decompression surgery (with or without stabilization)

Interventions

Intervention arm (n = 10): Standard lumbar decompression (with or without instrumentation). At the end of surgery, after decompression/instrumentation, haemostasis, warm saline irrigation and suction
the field is not re-irrigated afterwards
any drain is placed laterally, away from the gel
the wound is closed in layers. Control arm (n = 10): Identical standard lumbar spine surgery without any barrier agent. Allocation by random number table (1:1). Surgery is performed by consultant s
operating surgeon not blinded. Clinical follow-up at 1, 3 and 6 months
contrast-enhanced MRI at 6 months. Analysed by intention-to-treat.

Sponsors

University of Indonesia
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Undergoing lumbar decompression surgery (with or without stabilisation) at the participating hospitals during the study period 2. Aged 18 years or older 3. Willing to participate in the study (provided consent)

Exclusion criteria

Exclusion criteria: 1. History of previous spine surgery 2. Immune disorder or autoimmune disease 3. Spinal malignancy

Design outcomes

Primary

MeasureTime frame
Low back pain and leg pain measured using the Visual Analogue Scale at preoperative baseline and 1, 3 and 6 months postoperatively;Disability measured using the Oswestry Disability Index at preoperative baseline and 1, 3 and 6 months postoperatively;Severity of epidural fibrosis measured using contrast-enhanced (gadolinium) T2 axial MRI, graded 0–4 across four quadrants on five consecutive slices and averaged (Ross-type grading), at 6 months postoperatively

Secondary

MeasureTime frame
Postoperative complications measured using any deviation from the normal postoperative course at through 6 months

Countries

Indonesia

Contacts

Public ContactLatsarizul Alfariq Senja;Dewa Gde Prema Belantara;Ananda

;

latsarizul.alfariq@rs.ui.ac.id;prema.ananda97@gmail.com+62 (0)813 1586 9791;+62 (0)81310160634

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026